This Article Abstract Full Text (PDF) All Versions of this Article: 90/5/506    most recent 01.RES.0000013796.73742.C8v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Haritunians, T. Articles by Schanen, C. Search for Related Content PubMed PubMed Citation Articles by Haritunians, T. Articles by Schanen, C. Related Collections Cerebrovascular disease/stroke Cell biology/structural biology Cell signalling/signal transduction Genetics of Stroke Other Vascular biology

(Circulation Research. 2002;90:506.)
© 2002 American Heart Association, Inc.

Reports

CADASIL Notch3 Mutant Proteins Localize to the Cell Surface and Bind Ligand

Talin Haritunians, Jim Boulter, Carol Hicks, Jonathon Buhrman, Guy DiSibio, Carrie Shawber, Gerry Weinmaster, Donna Nofziger, Carolyn Schanen

From the Departments of Human Genetics (T.H., C.S.), Psychiatry and Biobehavioral Sciences (J.B.), and Biological Chemistry (C.H., G.D., C.S., G.W.), University of California, Los Angeles, and Natural Science Division (J.B., D.N.), Pepperdine University, Malibu, Calif.

Correspondence to Carolyn Schanen, MD, PhD, UCLA Department of Human Genetics, 695 Charles Young Dr South, Los Angeles, CA 90095. E-mail schanen{at}ucla.edu

Abstract

Cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a vascular dementia arising from abnormal arteriolar vascular smooth muscle cells. CADASIL results from mutations in Notch3 that alter the number of cysteine residues in the extracellular epidermal growth factor–like repeats, important for ligand binding. It is not known whether CADASIL mutations lead to loss or gain of Notch3 receptor function. To examine the functional consequences of CADASIL mutations, we engineered 4 CADASIL-like mutations into rat Notch3 and have shown that the presence of an unpaired cysteine does not impair cell-surface expression or ligand binding.

Key Words: CADASIL • Notch3 • vascular dementia • epidermal growth factor–like repeat • transmembrane receptor

Cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is an inherited vascular dementia caused by mutations in NOTCH3. Pathologically, CADASIL is characterized by replacement of arteriolar vascular smooth muscle cells (VSMCs) by a granular material that closely associates with Notch3 extracellular domain (N3ECD) immunoreactivity.^1,2 Consistent with the observed defects in CADASIL, arteriolar VSMCs express Notch3,^2,3 a member of a family of transmembrane receptors crucial for cell fate determinations.⁴ Notch receptors consist of an intracellular domain (ICD) required for signal transduction and an extracellular domain (ECD) containing 29 to 36 epidermal growth factor–like repeats (EGFRs), each with 6 conserved cysteines.⁴ EGFR-11 and -12 are required for DSL (Delta, Serrate, LAG2) ligand binding,⁵ and CADASIL mutations introduce or delete a single cysteine^1,6 within certain EGFRs. However, it is unknown whether CADASIL mutations lead to a loss or gain in Notch3 receptor function.

Mammalian Notch proteins are proteolytically processed by a furin-like convertase to produce a heterodimeric receptor.⁷ After DSL-ligand binding, additional proteolytic cleavage steps release the ICD, which translocates to the nucleus and interacts directly with the CSL (CBF/Su(H)/LAG1) transcription factor.⁸ In some systems, the Notch3 ICD (N3ICD) is a weak CSL activator, whereas in other systems it is comparable to the strong activity intrinsic to Notch1 ICD (N1ICD).^9,10 Although N3ICD antagonizes N1ICD-induced CSL activation,^9,11 ligand-induced activation of full-length Notch3 has not been reported. To study the effects of CADASIL mutations, CADASIL-like mutant Notch3 proteins were expressed in 293T human embryonal kidney (HEK) cells and assessed for cell surface expression and DSL ligand interaction.

Materials and Methods

Cloning, Sequencing, and Mutagenesis of Rat Notch3 cDNA Clones
A subcloned PCR fragment corresponding to mouse Notch3 nucleotides 288 to 1037 was used to screen E13 and adult rat brain cDNA libraries by standard procedures.¹² Clones pHIP105 (nucleotides 1 to 754) and pRB702 (nucleotides 755 to 7319) were ligated at an NdeI site, generating a clone encoding the entire rat Notch3 (rNotch3) sequence (GenBank AF164486). This construct (pN3.1) was C-terminally epitope-tagged with a tandem repeat of hemagglutinin (HA) using PCR and subcloned into the expression vector pEF1-BOS¹³ (pBOSN3HA). CADASIL-like mutations (R171C, H184C, C544Y, and R560C)¹ were introduced using site-directed mutagenesis (QuikChange, Stratagene).

Transfection, Biotinylation, and Immunoblotting
HEK293T cells were propagated as recommended by the American Type Culture Collection. Cells were transfected with 4 µg of DNA using lipofection (Cytofectene, BioRad). Cell surface proteins were labeled with 0.5 mg/mL Sulfo-NHS-Biotin (Pierce) and biotinylated proteins were purified on streptavidin (SA) beads (Pierce) as previously described.¹⁴ Proteins were resolved by SDS-PAGE and identified by immunoblotting with either 1:1000 anti-HA antibody (12CA5) or 1:10 000 anti-erk1 antibody (C-16, Santa Cruz), followed by ECL or ECL-Plus (Amersham-Pharmacia).

Ligand Binding Assay
Transfected cells were incubated for 1 hour at RT with Delta1Fc (D1Fc) conditioned medium (CM) preclustered with Fc antibodies conjugated with Texas Red (TR) as previously described.¹⁵ D1Fc binding was monitored by the TR fluorescence, detected using a Leica DM RXA microscope and cooled CCD camera.

Results and Discussion

CADASIL mutations identified to date alter cysteine residues in EGF modules, a structure that is dependent on 3 disulfide bridges formed between 6 invariant cysteines. To study the consequences of CADASIL mutations on protein stability and function, we cloned a rNotch3 cDNA that encodes a protein 93% and 84% homologous to mouse and human NOTCH3, respectively, and contains all characteristic structural motifs found in Notch proteins. We introduced the following single CADASIL-like mutations in rNotch3 (Figure 1)¹: R171C and H184C lie in EGFR-4 where CADASIL clustering is observed, whereas C544Y and R560C alter EGFR-13 and -14, which are near the Drosophila split loss-of-function mutant allele.¹⁶

View larger version (22K): [in this window] [in a new window]   Figure 1. Schematic representation of the processed rNotch3 protein with a C-terminal HA epitope tag. Like other mammalian Notch3 orthologues, the ECD of the receptor has 34 EGF-like repeats and LNR repeats. The p97 fragment contains the transmembrane domain, ankyrin repeats, and PEST sequences. The positions of the mutations examined in the present study are indicated.

The effects of these mutations on proteolytic processing and cell surface expression were assessed by transiently expressing wild-type (wt) and mutant Notch3 constructs in 293T cells. After biotinylation and immunoblotting with the 12CA5 antibody (Figure 2A), unprocessed full-length 280-kDa and processed 97-kDa polypeptides were detected in whole-cell lysates and SA precipitates from biotinylated transfected cells (Figure 2B). To ensure that detection of p280 Notch3 was not an artifact of inadvertent cell lysis, SA-precipitated proteins were probed with antibodies to the intracellular protein erk1. Although present in whole-cell lysates (Figure 2C), p44 erk1 was not detected among the biotinylated proteins (Figure 2D). Moreover, the ratio of p280 to p97 after SA precipitation was reversed relative to whole-cell lysates, indicating that the signal detected with SA precipitates is due to p280 and p97 cell surface expression. Normal processing and cell surface expression of these mutants suggest that the odd number of cysteines imposed by these mutations does not disrupt receptor maturation.

View larger version (55K): [in this window] [in a new window]   Figure 2. Cell surface expression and processing of wt and mutant Notch3 in transfected 293T cells. A, Expression of HA-tagged wt (pBOSN3HA) and mutant Notch3 proteins in transfected 293T cells were detected by immunoblotting whole-cell lysates with the 12CA5 HA antibody followed by ECL. Both the p280 unprocessed receptor and the processed p97 form were detected. No protein was detected in cells transfected with empty vector (pBOS) or with a vector encoding GFP-tagged Notch1. B, Transiently transfected 293T cells were biotinylated then precipitated with SA beads overnight. Immunoblotting with 12CA5 and ECL-Plus detected both the processed p97 fragment and the full-length p280 protein among the precipitated proteins from cells expressing wt or mutant Notch3. No protein was detected in cells transfected with empty vector or a vector encoding GFP-tagged Notch1. Differences in the apparent abundance of proteins between A and B result from the increased sensitivity of ECL-Plus. C and D, To ensure that the detection of p280 and p97 in the SA precipitates represents cell surface expression, evidence of intracellular p44 erk1 biotinylation was determined using -erk1 (C-16) and ECL. p44 erk1 was detected in whole-cell lysates from each of the transfected biotinylated cells (C) but was not detected in the SA-precipitated proteins (D).

The constructs were expressed in 293T cells and tested for their ability to bind a soluble form of the rat Delta1 ligand, D1Fc. D1Fc consists of the extracellular portion of Delta1 fused to the Fc domain of human IgG and has been shown to bind and activate Notch1.^15,17 D1Fc binding was detected with each Notch3 CADASIL mutant protein (Figures 3A through 3D) and appeared comparable to that detected for wt Notch3 (Figure 3E). No D1Fc binding was detected for cells transfected with the pBOS vector (Figure 3F) nor Notch3-expressing cells treated with clustered Fc CM (Figure 3G), indicating that the signal was specific for Delta1 and Notch3 sequences. Binding was also compared for D1Fc CM diluted 1:20, 1:30, and 1:50, and although binding affinities and on/off rates were not measured, no differences were detected with the different D1Fc CM concentrations (data not shown), suggesting that mutant and wt receptor–ligand interactions were qualitatively similar.

View larger version (50K): [in this window] [in a new window]   Figure 3. D1Fc ligand binding by wt and mutant Notch3 detected by TR fluorescence. Transiently transfected 293T cells expressing the mutant Notch3 proteins (A through D), wt Notch3 (E and G), or empty vector (F) were incubated with a 1:5 dilution of D1Fc CM (A through F) or Fc CM (G) and examined by fluorescence microscopy. The CADASIL mutants (A through D) bind D1Fc similar to wt Notch3 (E). No binding is detected for cells transfected with control vector pBOS (F) or for those incubated with Fc CM (G).

Our data suggest that CADASIL mutations act downstream of ligand binding, perhaps through disruption of ligand-induced shedding/clearance of the N3ECD, a process important for receptor activation.¹⁸ N3ECD accumulation in CADASIL vessels has been reported, although accumulation was not detected with HEK cells expressing CADASIL mutant Notch3 forms in the absence of DSL ligands.² Determination of whether ligand binding by these CADASIL mutants results in productive signaling is not straightforward, because ligand-induced Notch3 signaling has yet to be reported and both positive and negative activities have been reported for N3ICD. Nonetheless, experiments are in progress to determine whether abnormal accumulation or shedding of mutant ECD or disruption of Notch3 signaling underlies the pathogenesis of CADASIL.

Acknowledgments

This study was supported by grants from the American Heart Association (AHA9950030N) and the Laubisch Foundation to C.S., the NIH (R01 CA82980) to G.W., and the National Science Foundation (DBI-99-87543) to D.N. We thank David Chiu for assistance with figure preparation and Dr Suzanne Mann for expert technical assistance.

Received October 9, 2001; revision received February 13, 2002; accepted February 13, 2002.

References

1. Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, Alamowitch S, Domenga V, Cecillion M, Marechal E, Maciazek J, Vayssiere C, Cruaud C, Cabanis EA, Ruchoux MM, Weissenbach J, Bach JF, Bousser MG, Tournier-Lasserve E. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature. 1996; 383: 707–710.

2. Joutel A, Andreux F, Gaulis S, Domenga V, Cecillon M, Battail N, Piga N, Chapon F, Godfrain C, Tournier-Lasserve E. The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J Clin Invest. 2000; 105: 597–605.

3. Villa N, Walker L, Lindsell CE, Gasson J, Iruela-Arispe ML, Weinmaster G. Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. Mech Dev. 2001; 108: 161–164.

4. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science. 1999; 284: 770–776.

5. Rebay I, Fleming RJ, Fehon RG, Cherbas L, Cherbas P, Artavanis-Tsakonas S. Specific EGF repeats of Notch mediate interactions with Delta and Serrate: implications for Notch as a multifunctional receptor. Cell. 1991; 67: 687–699.

6. Joutel A, Vahedi K, Corpechot C, Troesch A, Chabriat H, Vayssiere C, Cruaud C, Maciazek J, Weissenbach J, Bousser M-G, Bach J-F, Tournier-Lasserve E. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet. 1997; 350: 1511–1515.

7. Logeat F, Bessia C, Brou C, LeBail O, Jarriault S, Seidah NG, Israël A. The Notch1 receptor is cleaved constitutively by a furin-like convertase. Proc Natl Acad Sci U S A. 1998; 95: 8108–8112.

8. Weinmaster G. Notch signal transduction: a real rip and more. Curr Opin Genet Dev. 2000; 10: 363–369.

9. Beatus P, Lundkvist J, Berg C, Lendahl U. The Notch 3 intracellular domain represses Notch 1-mediated activation through Hairy/Enhancer of split promoters. Development. 1999; 126: 3925–3935.

10. Mizutani T, Taniguchi Y, Aoki T, Hashimoto N, Honjo T. Conservation of the biochemical mechanisms of signal transduction among mammalian Notch family members. Proc Natl Acad Sci U S A. 2001; 98: 9026–9031.

11. Apelqvist A, Li H, Sommer L, Beatus P, Anderson DJ, Honjo T, Hrabe de Angelis M, Lendahl U, Edlund H. Notch signalling controls pancreatic cell differentiation. Nature. 1999; 400: 877–881.

12. Sambrook J, Fritsch E, Maniatis T. Molecular Cloning. 2nd ed. New York, NY: Cold Spring Harbor Press; 1989.

13. Mizushima S, Nagata S. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res. 1990; 18: 5322.

14. Bush G, diSibio G, Miyamoto A, Denault JB, Leduc R, Weinmaster G. Ligand-induced signaling in the absence of furin processing of Notch1. Dev Biol. 2001; 229: 494–502.

15. Hicks C, Johnston SH, diSibio G, Collazo A, Vogt TF, Weinmaster G. Fringe differentially modulates Jagged1 and Delta1 signalling through Notch1 and Notch2. Nat Cell Biol. 2000; 2: 515–520.

16. Lieber T, Wesley CS, Alcamo E, Hassel B, Krane JF, Campos-Ortega JA, Young MW. Single amino acid substitutions in EGF-like elements of Notch and Delta modify Drosophila development and affect cell adhesion in vitro. Neuron. 1992; 9: 847–859.

17. Wang S, Sdrulla AD, diSibio G, Bush G, Nofziger D, Hicks C, Weinmaster G, Barres BA. Notch receptor activation inhibits oligodendrocyte differentiation. Neuron. 1998; 21: 63–75.

18. Rand MD, Grimm LM, Artavanis-Tsakonas S, Patriub V, Blacklow SC, Sklar J, Aster JC. Calcium depletion dissociates and activates heterodimeric Notch receptors. Mol Cell Biol. 2000; 20: 1825–1835.

This article has been cited by other articles:

				C. Roca and R. H. Adams Regulation of vascular morphogenesis by Notch signaling Genes & Dev., October 15, 2007; 21(20): 2511 - 2524. [Abstract] [Full Text] [PDF]

				K. Niessen and A. Karsan Notch signaling in the developing cardiovascular system Am J Physiol Cell Physiol, July 1, 2007; 293(1): C1 - C11. [Abstract] [Full Text] [PDF]

				T Haritunians, T Chow, R P J De Lange, J T Nichols, D Ghavimi, N Dorrani, D M St Clair, G Weinmaster, and C Schanen Functional analysis of a recurrent missense mutation in Notch3 in CADASIL J. Neurol. Neurosurg. Psychiatry, September 1, 2005; 76(9): 1242 - 1248. [Abstract] [Full Text] [PDF]

				J. F. Arboleda-Velasquez, R. Rampal, E. Fung, D. C. Darland, M. Liu, M. C. Martinez, C. P. Donahue, M. F. Navarro-Gonzalez, P. Libby, P. A. D'Amore, et al. CADASIL mutations impair Notch3 glycosylation by Fringe Hum. Mol. Genet., June 15, 2005; 14(12): 1631 - 1639. [Abstract] [Full Text] [PDF]

				J.-C. Tille and M.S. Pepper Hereditary Vascular Anomalies: New Insights Into Their Pathogenesis Arterioscler Thromb Vasc Biol, September 1, 2004; 24(9): 1578 - 1590. [Abstract] [Full Text] [PDF]

				M. B. Hussain, S. Singhal, H. S. Markus, and D. R.J. Singer Abnormal Vasoconstrictor Responses to Angiotensin II and Noradrenaline in Isolated Small Arteries From Patients With Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Stroke, April 1, 2004; 35(4): 853 - 858. [Abstract] [Full Text] [PDF]

				T. Gridley Notch signaling and inherited disease syndromes Hum. Mol. Genet., April 2, 2003; 12(90001): R9 - 13. [Abstract] [Full Text] [PDF]

				T. Iso, Y. Hamamori, and L. Kedes Notch Signaling in Vascular Development Arterioscler Thromb Vasc Biol, April 1, 2003; 23(4): 543 - 553. [Abstract] [Full Text] [PDF]

				M. M. Ruchoux, V. Domenga, P. Brulin, J. Maciazek, S. Limol, E. Tournier-Lasserve, and A. Joutel Transgenic Mice Expressing Mutant Notch3 Develop Vascular Alterations Characteristic of Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy Am. J. Pathol., January 1, 2003; 162(1): 329 - 342. [Abstract] [Full Text] [PDF]

				H. Karlstrom, P. Beatus, K. Dannaeus, G. Chapman, U. Lendahl, and J. Lundkvist A CADASIL-mutated Notch 3 receptor exhibits impaired intracellular trafficking and maturation but normal ligand-induced signaling PNAS, December 24, 2002; 99(26): 17119 - 17124. [Abstract] [Full Text] [PDF]

				J. F. Arboleda-Velasquez, F. Lopera, E. Lopez, M. P. Frosch, D. Sepulveda-Falla, J. E. Gutierrez, S. Vargas, M. Medina, C. Martinez de Arrieta, R. V. Lebo, et al. C455R notch3 mutation in a Colombian CADASIL kindred with early onset of stroke Neurology, July 23, 2002; 59(2): 277 - 279. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) All Versions of this Article: 90/5/506    most recent 01.RES.0000013796.73742.C8v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Haritunians, T. Articles by Schanen, C. Search for Related Content PubMed PubMed Citation Articles by Haritunians, T. Articles by Schanen, C. Related Collections Cerebrovascular disease/stroke Cell biology/structural biology Cell signalling/signal transduction Genetics of Stroke Other Vascular biology